Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FD4RJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of XTANDI 80 mg with a ceiling value of $4,169.59. The award, issued on October 30, 2025, utilizes firm fixed-price pricing with an ultimate completion date of October 31, 2025. This delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contractor will perform the work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of prescription drugs, biologics, and medical supplies. XTANDI, an oncology treatment, aligns with the contractor's demonstrated portfolio of specialty pharmaceuticals supplied to federal agencies under this prime vendor framework.
Quick answers
Who was awarded contract SPE2DB26FD4RJ?
SPE2DB26FD4RJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FD4RJ worth?
The government has obligated $4,170 on SPE2DB26FD4RJ.
Is contract SPE2DB26FD4RJ an order under another contract?
Yes. SPE2DB26FD4RJ is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB26FD4RJ competed?
The extent of competition for SPE2DB26FD4RJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award